Literature DB >> 20195681

Complete response of anaplastic pancreatic carcinoma to paclitaxel treatment selected by chemosensitivity testing.

Takeru Wakatsuki1, Atsushi Irisawa, Hidemichi Imamura, Masanori Terashima, Goro Shibukawa, Tadayuki Takagi, Yuta Takahashi, Ai Sato, Masaki Sato, Tsunehiko Ikeda, Rei Suzuki, Takuto Hikichi, Katsutoshi Obara, Hiromasa Ohira.   

Abstract

A 58-year-old woman was admitted to our institute in June 2007 because of obstructive jaundice. A mass in the pancreatic head and multiple swollen lymph nodes surrounding the common hepatic artery were identified using computed tomography (CT). Subsequently, endoscopic ultrasonography-guided fine-needle aspiration biopsy (EUS-FNA) was done. Histopathologic results revealed anaplastic carcinoma of the pancreas. Using specimens obtained with EUS-FNA, chemosensitivity testing with adenosine triphosphate assay was performed. Testing indicated high chemosensitivity to paclitaxel (PTX). According to this result, chemotherapy using PTX was performed, and the primary lesion and lymph node metastases disappeared completely on CT. The patient has been doing well with no recurrence for 1 year and 11 months since initial chemotherapy.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20195681     DOI： 10.1007/s10147-010-0038-9

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN： 1341-9625            Impact factor:   3.402


  23 in total

Review 1.  Pancreatic head mass: what can be done? Classification: the pathological point of view.

Authors:  G Zamboni; P Capelli; A Pesci; S Beghelli; J Lüttges; G Klöppel
Journal:  JOP       Date:  2000-09

Review 2.  Anaplastic carcinoma of the pancreas associated with a mucinous cystic adenocarcinoma. A case report and review of the literature.

Authors:  Zeng Gang Pan; Bo Wang
Journal:  JOP       Date:  2007-11-09

3.  Morphological study of 391 cases of exocrine pancreatic tumours with special reference to the classification of exocrine pancreatic carcinoma.

Authors:  J Chen; S I Baithun
Journal:  J Pathol       Date:  1985-05       Impact factor: 7.996

Review 4.  Anaplastic pancreatic carcinoma. A case report and review of literature .

Authors:  Manpreet K Chadha; Charles LeVea; Milind Javle; Boris Kuvshinoff; Rekha Vijaykumar; Renuka Iyer
Journal:  JOP       Date:  2004-11-10

5.  Treatment with taxanes of refractory or life-threatening Kaposi sarcoma not associated with human immunodeficiency virus infection.

Authors:  Laurence Fardet; Pierre-Emmanuel Stoebner; Herve Bachelez; Vincent Descamps; Delphine Kerob; Laurent Meunier; Michel Dandurand; Patrice Morel; Celeste Lebbe
Journal:  Cancer       Date:  2006-04-15       Impact factor: 6.860

6.  Clinical experience with combination paclitaxel and carboplatin therapy for advanced or recurrent carcinosarcoma of the uterus.

Authors:  Masafumi Toyoshima; Jun-Ichi Akahira; Gen Matsunaga; Hitoshi Niikura; Kiyoshi Ito; Nobuo Yaegashi; Toru Tase
Journal:  Gynecol Oncol       Date:  2004-09       Impact factor: 5.482

7.  A new in-vitro drug sensitivity test (collagen-gel droplet embedded-culture drug sensitivity test) in carcinomas of pancreas and biliary tract: possible clinical utility.

Authors:  H Yasuda; T Takada; K Wada; H Amano; T Isaka; M Yoshida; T Uchida; N Toyota
Journal:  J Hepatobiliary Pancreat Surg       Date:  1998

8.  Combination chemotherapy with carboplatin, paclitaxel and pegylated liposomal doxorubicin for advanced or recurrent carcinosarcoma of the uterus: clinical experience of a single institution.

Authors:  Dimitrios Pectasides; Eirini Pectasides; George Papaxoinis; Nikolaos Xiros; Constantinos Sykiotis; Antonios Papachristodoulou; Nikolaos Tountas; John Panayiotides; Theofanis Economopoulos
Journal:  Gynecol Oncol       Date:  2008-07-07       Impact factor: 5.482

9.  Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma.

Authors:  Anil Tulpule; Jerome Groopman; M Wayne Saville; William Harrington; Alvin Friedman-Kien; Byron M Espina; Carlos Garces; Lily Mantelle; Karl Mettinger; David T Scadden; Parkash S Gill
Journal:  Cancer       Date:  2002-07-01       Impact factor: 6.860

10.  Pleomorphic carcinoma of the pancreas: reappraisal of surgical resection.

Authors:  K Yamaguchi; K Nakamura; S Shimizu; K Yokohata; T Morisaki; K Chijiiwa; M Tanaka
Journal:  Am J Gastroenterol       Date:  1998-07       Impact factor: 10.864
View more
  13 in total

1.  Anaplastic adenocarcinoma of the pancreas.

Authors:  Nickos Michalopoulos; Styliani Laskou; Yiorgos Papadakis; Georgia Karayannopoulou; Ioannis Kanellos
Journal:  J Gastrointest Cancer       Date:  2015-03

2.  Drug Selection in the Genomic Age: Application of the Coexpression Extrapolation Principle for Drug Repositioning in Cancer Therapy.

Authors:  Daniel L Gustafson; Jared S Fowles; Kristen C Brown; Dan Theodorescu
Journal:  Assay Drug Dev Technol       Date:  2015-12       Impact factor: 1.738

3.  ATP assay-guided chemosensitivity testing for gemcitabine with biopsy specimens obtained from unresectable pancreatic cancer using endoscopic ultrasonography-guided fine-needle aspiration.

Authors:  Takeru Wakatsuki; Atsushi Irisawa; Masanori Terashima; Goro Shibukawa; Tadayuki Takagi; Hidemichi Imamura; Yuta Takahashi; Ai Sato; Masaki Sato; Tsunehiko Ikeda; Rei Suzuki; Takuto Hikichi; Katsutoshi Obara; Hiromasa Ohira
Journal:  Int J Clin Oncol       Date:  2011-02-18       Impact factor: 3.402

4.  A spindle cell anaplastic pancreatic carcinoma with rhabdoid features following curative resection.

Authors:  Tomoyuki Abe; Hironobu Amano; Keiji Hanada; Akihisa Okazaki; Shuji Yonehara; Fumito Kuranishi; Masahiro Nakahara; Yoshinori Kuroda; Toshio Noriyuki
Journal:  Mol Clin Oncol       Date:  2016-05-30

5.  A case report of anaplastic carcinoma of the pancreas with remarkable intraductal tumor growth into the main pancreatic duct.

Authors:  Mitsuyoshi Okazaki; Isamu Makino; Hirohisa Kitagawa; Shinichi Nakanuma; Hironori Hayashi; Hisatoshi Nakagawara; Tomoharu Miyashita; Hidehiro Tajima; Hiroyuki Takamura; Tetsuo Ohta
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

6.  Prospective clinical trial testing COXEN-based gene expression models of chemosensitivity in dogs with spontaneous osteosarcoma.

Authors:  Daniel L Gustafson; Keagan P Collins; Jared S Fowles; E J Ehrhart; Kristen M Weishaar; Sunetra Das; Dawn L Duval; Douglas H Thamm
Journal:  Cancer Chemother Pharmacol       Date:  2021-07-14       Impact factor: 3.333

7.  Anaplastic carcinoma of the pancreas mimicking submucosal gastric tumor: a case report of a rare tumor.

Authors:  Michimasa Fujiogi; Takashi Kobayashi; Masamichi Yasuno; Michio Tanaka
Journal:  Case Rep Med       Date:  2013-12-08

8.  Case of Six-Year Disease-Free Survival with Undifferentiated Carcinoma of the Pancreas.

Authors:  Hiroyuki Saito; Hiroshi Kashiyama; Takashi Murohashi; Kazunari Sasaki; Ryosuke Misawa; Susumu Ohwada
Journal:  Case Rep Gastroenterol       Date:  2016-08-31

Review 9.  Anaplastic carcinoma of the pancreas diagnosed by endoscopic ultrasound-guided fine-needle aspiration: a case report and review of the literature.

Authors:  Kohei Oka; Ken Inoue; Satoshi Sugino; Taishi Harada; Toshifumi Tsuji; Shingo Nakashima; Takayuki Katayama; Takashi Okuda; Syuichi Kin; Akihiro Nagata; Toshiyuki Komaki; Keizo Kagawa
Journal:  J Med Case Rep       Date:  2018-05-31

10.  Establishment and characterization of new cell lines of anaplastic pancreatic cancer, which is a rare malignancy: OCUP-A1 and OCUP-A2.

Authors:  Kotaro Miura; Kenjiro Kimura; Ryosuke Amano; Sadaaki Yamazoe; Go Ohira; Akihiro Murata; Kohei Nishio; Tsuyoshi Hasegawa; Masakazu Yashiro; Bunzo Nakata; Masaichi Ohira; Kosei Hirakawa
Journal:  BMC Cancer       Date:  2016-04-11       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.